Labels: sources manual selection automatic selection
Rehabilitacion (Madr). 2022 Nov 5:S0048-7120(22)00073-1. doi: 10.1016/j.rh.2022.05.004. Online ahead of print.
NO ABSTRACT
PMID:36347657 | DOI:10.1016/j.rh.2022.05.004
Continue Reading
Background
The prevalence of depressive symptoms in people with Multiple Sclerosis (MS) is around 25 – 50% and affects their daily life and general quality of life. Several studies investigating therapeutic exercise have shown …
Continue Reading
jats:titleAbstractjats:sec jats:titleBackground jats:pCladribine is a synthetic purine analogue that interferes with DNA synthesis and repair next to disrupting cellular proliferation in actively dividing lymphocytes. The compound …
Continue Reading
Cell Immunol. 2022 Nov 3;382:104637. doi: 10.1016/j.cellimm.2022.104637. Online ahead of print.
ABSTRACT
Multiple sclerosis is believed to be triggered by the interplay between the environmental and genetic factors. In contrast to …
Continue Reading
Proc Natl Acad Sci U S A. 2022 Nov 16;119(46):e2120393119. doi: 10.1073/pnas.2120393119. Epub 2022 Nov 7.
ABSTRACT
Failure of remyelination underlies the progressive nature of demyelinating diseases such as multiple sclerosis. Why …
Continue Reading
Background
B-cell depleting medications are effective disease-modifying therapies for multiple sclerosis. Prior studies have demonstrated that use of these medication is associated with infections and immunologic changes. Limited …
Continue Reading
Background\nMotor dysfunctions in people with multiple sclerosis (pwMS) are frequently due to muscle weakness, abnormal walking biomechanics, balance impairments, spasticity and fatigue. Since MS is typically diagnosed in young …
Continue Reading
Background
Cognitive impairment is common in patients with multiple sclerosis, even in the early stages of the disease. The Brief International Cognitive Assessment for multiple sclerosis (BICAMS) is a short screening tool …
Continue Reading
Articles listed here come from the following sites, with keyword searches for Multiple Sclerosis, autoimmune encephalomyelitis, encephalomyelitis, immune tolerance, myelin.